アブストラクト | Chimeric antigen receptor T-cell (CAR-T) therapy has achieved durable response in patients with hematological malignancies, however, therapy-associated multisystem toxicities are commonly observed. Here, we systematically analyzed CAR-T-related gastrointestinal adverse events (GAEs) using the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) between January 2017 and December 2021. Disproportionality analyses were performed using reporting odds ratios (ROR) and information component (IC). Among 105,087,611 reports in FAERS, 1518 CAR-T-related GAEs reports were identified. 23 GAEs (n = 281, 18.51%) were significantly overreported following CAR-T therapy compared with the full database, of which 11 GAEs (n = 156, 10.28%) were associated with gastrointestinal infections (GI), such as clostridium difficile colitis (n = 44 [2.90%], ROR = 5.55), enterovirus infection (n = 23 [1.52%], ROR = 20.02), and mucormycosis (n = 15 [0.99%], ROR = 3.09). Overall, the fatality rate of 11 GI-related AEs was 29.49%, especially mucormycosis causing substantial mortality with 60%. In addition, 4 of 23 overreported GAEs were related to haemorrhage and the mortality of gastrointestinal haemorrhage was 73.17%. Lastly, 29 death-related GAEs were identified. These findings could help clinicians early alert those rarely reported but lethal GAEs, thus reducing the risk of severe toxicities. |
ジャーナル名 | Cancer gene therapy |
Pubmed追加日 | 2024/3/29 |
投稿者 | Song, Zhiqiang; Wang, Yang; Liu, Ping; Geng, Yuke; Liu, Na; Chen, Jie; Yang, Jianmin |
組織名 | Department of Hematology, Institute of Hematology, Changhai Hospital, Second;Military Medical University, Shanghai, 200433, China.;Military Medical University, Shanghai, 200433, China. liuna2015@sibs.ac.cn.;Military Medical University, Shanghai, 200433, China. chenjiedoctor@163.com.;Military Medical University, Shanghai, 200433, China. yangjianmin123@smmu.edu.cn. |
Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/38548883/ |